NEW YORK – Molecular diagnostics company Genedrive announced Monday that its antibiotic-induced hearing loss test, the Genedrive MT-RNR1 ID kit, obtained CE marking.
The test will be used to screen babies for a genetic mutation that can cause lifelong deafness when they are given certain antibiotics. The company said in a statement the RNR1 test is believed to be the first commercial genetic screening test designed for use in an infant emergency care environment.